{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:03:54Z","timestamp":1784178234751,"version":"3.55.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence suggesting that hepatocellular carcinoma (HCC) arising in patients with metabolic-associated fatty liver disease (MAFLD) is associated with better outcomes than HCC related to other liver diseases has been derived largely from non-Western cohorts and has incompletely accounted for the severity of underlying liver disease. Whether MAFLD independently influences survival after hepatic resection, particularly in Western populations, remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-center cohort study, adults who underwent curative-intent hepatic resection for HCC at a Western academic center were evaluated. Patients managed without surgery were excluded. MAFLD was defined according to international consensus criteria. In the primary analysis, patients were classified as MAFLD-positive if they fulfilled MAFLD criteria and had no competing chronic liver disease etiology. Overall survival (OS) and disease-free survival (DFS) were assessed with Cox proportional-hazards models adjusted for cirrhosis, albumin-bilirubin grade, tumor burden, performance status, and alpha-fetoprotein level among other confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 156 patients, 89 (57.1%) were classified as MAFLD-positive. As compared with MAFLD-negative patients, MAFLD-positive patients were older, more frequently obese and diabetic, and less likely to have cirrhosis (all P \u2264 0.043). Open or hybrid resection was more common in the MAFLD-positive group, whereas minimally invasive resection was more common in the MAFLD-negative group (67.4% vs. 44.8% and 32.6% vs. 55.2%, respectively; P\u00a0=\u00a00.006). In unadjusted analyses, MAFLD-positive status was associated with longer DFS and a trend towards longer OS; however, these associations were attenuated after multivariable adjustment. MAFLD was not independently associated with OS (adjusted hazard ratio, 0.91; 95% confidence interval [CI], 0.45 to 1.84; P\u00a0=\u00a00.785) or DFS (adjusted hazard ratio, 0.58; 95% CI, 0.28 to 1.19; P\u00a0=\u00a00.139). Cirrhosis, impaired performance status, elevated alpha-fetoprotein, and greater tumor burden were the principal predictors of postoperative outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this Western resection cohort, MAFLD was not independently associated with OS or DFS after curative hepatectomy once liver disease severity and tumor burden were taken into account. Prognosis was driven primarily by established hepatic and oncologic factors rather than metabolic etiology alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1793271","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:05Z","timestamp":1784175665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Michele","family":"Molinari","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrishketan","family":"Sethi","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Kaltenmeier","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiha","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkay","family":"Demirors","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Yu-Sheng Lin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Kaohsiung Medical University","place":["Kaohsiung, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Mial-Anthony","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dooman","family":"Arefan","sequence":"additional","affiliation":[{"name":"University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandong","family":"Wu","sequence":"additional","affiliation":[{"name":"University of Pittsburgh","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Buros","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Houston Methodist Hospital","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Minervini","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Tohme","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Geller","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Furlan","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12625","article-title":"The impact of hepatitis C burden: an evidence-based approach","volume":"39","author":"Younossi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population","volume":"13","author":"Mittal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms26010306","article-title":"NAFLD and NAFLD-related HCC: Emerging treatments and clinical trials","volume":"26","author":"Khare","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12762","article-title":"Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection","volume":"47","author":"Kimura","year":"2017","journal-title":"Hepatol Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jamcollsurg.2019.07.012","article-title":"Liver resection for nonalcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"229","author":"Koh","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13760","article-title":"Diabetes mellitus and\/or nonalcoholic steatohepatitis-related hepatocellular carcinoma showed favorable surgical outcomes after hepatectomy","volume":"39","author":"Liang","year":"2019","journal-title":"Anticancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-015-1295-x","article-title":"Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease","volume":"400","author":"Mikuriya","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.33713","article-title":"Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis","volume":"36","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4181-9","article-title":"Impact of hepatic steatosis on disease-free survival in patients with non-B non-C hepatocellular carcinoma undergoing hepatic resection","volume":"22","author":"Nishio","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4221-5","article-title":"Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection","volume":"22","author":"Su","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-011-1540-8","article-title":"Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease","volume":"15","author":"Wakai","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2011.04.004","article-title":"Prognostic effect of steatosis on hepatocellular carcinoma patients after liver resection","volume":"37","author":"Wu","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15026","article-title":"Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma","volume":"35","author":"Yoon","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/as9.0000000000000065","article-title":"Hepatic resection for hepatocellular carcinoma in nonalcoholic fatty liver disease: A systematic review and meta-analysis of 7226 patients","volume":"2","author":"Molinari","year":"2021","journal-title":"Ann Surg Open"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrac167","article-title":"Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis","volume":"7","author":"Su","year":"2023","journal-title":"BJS Open"},{"key":"B24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2015.01.024","article-title":"Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC","volume":"63","author":"Vigano","year":"2015","journal-title":"J Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.8963","article-title":"Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome","volume":"100","author":"Cauchy","year":"2013","journal-title":"Br J Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-18422-2","article-title":"Robotic right hepatectomy for peri-hilar cholangiocarcinoma after liver venous deprivation","volume":"33","author":"Conci","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25536","article-title":"Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease","volume":"55","author":"Reddy","year":"2012","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32511-3","article-title":"Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease","volume":"46","author":"Wong","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1016\/s0168-8278(23)01243-6","article-title":"Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology","volume":"14","author":"Beudeker","year":"2024","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.22530","article-title":"The 2024 revision to the Declaration of Helsinki: Modern ethics for medical research","volume":"333","author":"Bibbins-Domingo","year":"2025","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.ad","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"B32","unstructured":"What is metabolic syndrome?"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100810","article-title":"Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma","volume":"5","author":"Song","year":"2023","journal-title":"JHEP Rep"},{"key":"B34","article-title":"American society of anesthesiologists physical status classification system","author":"Hendrix","year":"2025","journal-title":"StatPearls"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1159\/000503095","article-title":"Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for cancer patients by oncology healthcare professionals","volume":"12","author":"Azam","year":"2019","journal-title":"Case Rep Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.21203\/rs.3.rs-1487018\/v1","article-title":"Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization","volume":"22","author":"Ananchuensook","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22745","article-title":"Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient","volume":"49","author":"Calvaruso","year":"2009","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12072-013-9484-6","article-title":"Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients","volume":"8","author":"Ferenci","year":"2014","journal-title":"Hepatol Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-020-04627-1","article-title":"Metavir fibrosis stage in hepatitis C-related hepatocellular carcinoma and association with noninvasive liver reserve models","volume":"24","author":"Ho","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12152","article-title":"Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China","volume":"8","author":"Liao","year":"2017","journal-title":"Oncotarget"},{"key":"B41","unstructured":"Risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.21037\/tgh.2019.09.01","article-title":"Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease\u2014one of a kind or two different enemies","volume":"4","author":"Pocha","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"B43","article-title":"Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: a multivariate, single-center analysis","volume":"34","author":"Hoffmann","year":"2014","journal-title":"Anticancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1245\/aso.2003.09.012","article-title":"Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital","volume":"10","author":"Yeh","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11938-004-0002-8","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak","year":"2018","journal-title":"Radiology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00261-017-1209-1","article-title":"Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis","volume":"43","author":"Tang","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-2343","article-title":"The role of platelet-lymphocyte ratio in hepatocellular carcinoma: a valuable prognostic marker","volume":"11","author":"Chan","year":"2022","journal-title":"Transl Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000521374","article-title":"Newly developed modified ALBI grade shows better prognostic and predictive value for hepatocellular carcinoma","volume":"11","author":"Kudo","year":"2022","journal-title":"Liver Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2147\/jhc.s486955","article-title":"MRI features and neutrophil-to-lymphocyte ratio (NLR)-based nomogram to predict prognosis of microvascular invasion-negative hepatocellular carcinoma","volume":"12","author":"Wei","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/srep35378","article-title":"Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1159\/000485396","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as prognostic predictors for hepatocellular carcinoma patients with various treatments: a meta-analysis and systematic review","volume":"44","author":"Zheng","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2016-000042","article-title":"Cancer and liver cirrhosis: implications on prognosis and management","volume":"1","author":"Pinter","year":"2016","journal-title":"ESMO Open"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/srep23608","article-title":"Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC","volume":"6","author":"Ande","year":"2016","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002089","article-title":"From MAFLD to hepatocellular carcinoma and everything in between","volume":"135","author":"Bae","year":"2022","journal-title":"Chin Med J (Engl)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1793271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:08Z","timestamp":1784175668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1793271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":55,"alternative-id":["10.3389\/fonc.2026.1793271"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1793271","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1793271"}}